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Abstract In addition to its well-recognized antimi-
crobial properties, lysozyme can also modulate the
inflammatory response. This ability may be particu-
larly important in the gastrointestinal tract where
inappropriate inflammatory reactions can damage the
intestinal epithelium, leading to significant health
problems. The consumption of milk from transgenic
goats producing human lysozyme (hLZ) in their milk
therefore has the potential to positively impact
intestinal health. In order to investigate the effect of
hLZ-containing milk on the inflammatory response,
young pigs were fed pasteurized milk from hLZ or
non-transgenic control goats and quantitative real-
time PCR was performed to assess local expression of
TNF-a, IL-8, and TGF-b1 in the small intestine.
Histological changes were also investigated, specif-
ically looking at villi width, length, crypt depth, and
lamina propria thickness along with cell counts for
intraepithelial lymphocytes and goblet cells. Signif-
icantly higher expression of anti-inflammatory cyto-
kine TGF-b1 was seen in the ileum of pigs fed
pasteurized milk containing hLZ (P = 0.0478), along
with an increase in intraepithelial lymphocytes
(P = 0.0255), and decrease in lamina propria thick-
ness in the duodenum (P = 0.0001). Based on these
results we conclude that consuming pasteurized milk
containing hLZ does not induce an inflammatory
response and improves the health of the small
intestine in pigs.
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Introduction
The cells that comprise the gastrointestinal (GI)
epithelium are continuously exposed to a variety of
microorganisms, nutrients, and antigens. These cells
must be able to distinguish between beneficial and
pathogenic commensal and transient microbiota
(Dwinell et al. 2003; Muller et al. 2005), as well as
bacterial breakdown products and food antigens
(Arnett and Viney 2009). To achieve this goal, the
intestinal mucosa must develop a degree of immu-
nological tolerance to the enormous bacterial burden
present in the gut (Duerkop et al. 2009). However, in
the face of GI infection, a quick and sufficient
immune response is necessary to eliminate pathogens
in order to prevent systemic disease (Eckmann 2006).
These responses must be well-modulated in order to
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minimize inflammation so that the absorptive func-
tion of the GI epithelium is maintained. Prolonged
inflammation in the GI tract as a result of pathogenic
infection or exposure to inflammatory antigens can
lead to significant destruction of the intestinal
epithelia, causing reduced absorptive capacity, mal-
nutrition, and impairment of growth. (Lunn 2000).
The protein lysozyme is an important non-specific
antimicrobial factor in many body secretions includ-
ing milk, saliva, and intestinal mucus. It also
possesses the ability to modulate the inflammatory
response through several mechanisms (Goldman
et al. 1986). Lysozyme binds lipopolysaccharides
(LPS), lipoteichoic acid (LTA), and peptidoglycan,
preventing them from interacting with receptors on
intestinal epithelial cells (IEC’s) and intestinal mac-
rophages (Ginsburg 2002; Ohno and Morrison
1989a). Sequestration of LPS by lysozyme suppresses
pro-inflammatory effects, including production of
TNF-a (Ohno and Morrison 1989b; Kurasawa et al.
1996; Takada et al. 1994a, b). Using a porcine model
of chemically induced colitis, investigators were able
to decrease expression of pro-inflammatory cyto-
kines, including TNF-a and IL-8, as well as increase
expression of anti inflammatory cytokines, including
TGF-b1, through oral administration of hen egg
white lysozyme (Lee et al. 2009). Lysozyme also has
significant immunomodulatory effects on neutrophils,
decreasing several responses to pro-inflammatory
agents and decreases oxidative metabolism in neu-
trophils without suppressing phagocytosis (Gordon
et al. 1979).
Ruminants naturally produce extremely low levels
of lysozyme in their milk however; our laboratory has
created transgenic dairy goats that produce approx-
imately two thirds the amount of lysozyme produced
in human milk (Maga et al. 2006a). The human
lysozyme (hLZ)-containing milk produced by these
goats has been proven active against E.coli and other
bacteria during both in vitro (Maga et al. 2006b) and
in vivo studies (Maga et al. 2006c). In addition,
feeding pasteurized hLZ milk to young pigs resulted
in improved gastrointestinal tract morphology with-
out raising levels of white blood cells (Brundige et al.
2008) as well as beneficially changing the serum
metabolome (Brundige et al. 2009). The modulation
of gut microbiota induced by consumption of hLZ
milk therefore has the potential to influence intestinal
immune response function.
Gut microbiota play a major role in the develop-
ment and maturation of the innate and adaptive
immune systems in the intestinal epithelium. Com-
mensal bacteria can exert a protective effect on the
gut by blocking activation of pro-inflammatory
pathways such as the NF-jB pathway (Schottelius
and Baldwin 1999; Mumy and McCormick 2005;
Duerkop et al. 2009), as well as activating the IjB
pathway, which inhibits NF-jB (Sharma and Tepas
2010). NF-jB is an immediate, early-response tran-
scription factor that can be activated by pathogenic
bacteria and bacterial breakdown products such as
LPS (Lalle`s 2010). When activated, NF-jB induces
the expression of chemokine and cytokine genes,
including IL-8 and TNF-a (Li and Stark 2002).
The pro-inflammatory cytokine TNF-a decreases
tight junction barrier function in IEC’s (Turner 2009),
which activates the leak pathway, thereby allowing
large solutes, including LPS, to pass through the tight
junctions and activate the NF-jB pathway, further
increasing the inflammatory response (Turner 2009).
Il-8, another pro-inflammatory cytokine, attracts
macrophages, neutrophils, polymorphonuclear leuko-
cytes (PMNs), and phagocytes as a first step in
recruitment and induction of an inflammatory
response (Dwinell et al. 2003). When activated,
intestinal macrophages and phagocytes can also
release proteases, oxygen radicals, and nitrogen
metabolites (e.g. NO2
-) which can cause damage to
the intestine (Pathmakanthan and Hawkey 2000).
Cytokines are also responsible for dampening pro-
inflammatory signals, especially TGF-b1 (Sharma and
Tepas 2010). TGF-b1, or transforming growth factor
b1, is involved in multiple biological processes such
as cell proliferation, migration, differentiation, extra
cellular matrix deposition, and immune regulation
(Brenmoehl et al. 2009). TGF-b1 causes differentia-
tion of T regulatory (Treg) cells, which negatively
regulate immunity. It also inhibits NK cells, mast
cells, granulocytes and macrophages. Recently TGF-
b1, in conjunction with IL-6, has been shown to be
necessary for Th17 cell differentiation. Th17 cells are
highly active during an inflammatory response. The
functions of Treg and Th17 cells are opposite, one
being involved in immune tolerance and the other in
inflammation. The regulatory pathways that TGF-b1
modulates to control differentiation of these two
immune cell types are currently being explored
(Awasthi and Kuchroo 2009; Yoshimura et al. 2010).
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In order to investigate the effects of hLZ trans-
genic goats’ milk on the intestinal immune response,
multiple feeding studies were conducted in pigs, as
they share a similar gastrointestinal morphology and
physiology to humans and therefore are an attractive
model (Domeneghini et al. 2006; Blachier et al.
2007). Gastrointestinal morphology and cytokine
levels in pro- and anti-inflammatory pathways were
analyzed to determine the effects of consumtion of
hLZ-containing milk on villus morphology and
immune regulation in the small intestine.
Materials and methods
Animals, necropsy, and sample collection
Samples from four separate feeding trials were
analyzed for this study. Details of each feeding trial
are outlined in Table 1. Pigs were kept in a temper-
ature-controlled environmental chamber between 25
and 27C for the course of the trial. Pigs were
monitered twice daily for physical and general well-
being. The diet and rearing of the pigs used for this
study has been previously described (Brundige et al.
2008). Pigs from the 2004, 2006, and 2008 trials were
fed 250 mL of hLZ-containing or control milk twice
daily. Pigs from the 2009 study were fed 250 mL of
either hLZ-containing or control milk twice daily for
1 week, then brought up to 350 mL twice daily for
the remainder of the study. Milk samples were
collected weekly for western blot analysis to confirm
hLZ protein level. Care and milking of goats has also
been previously described (Brundige et al. 2008). All
animals were cared for under Association for Assess-
ment and Accreditation of Laboratory Animal Care
International (AAALAC) approved conditions.
At the end of each trial, pigs were weighed and
necropsied by an American College of Veterinary
Pathologist (ACVP) board-certified animal patholo-
gist at the California Animal Health and Food Safety
(CAFHS) laboratory (UC Davis, Davis, CA, USA).
The necropsy procedure, including euthanasia of
animals, collection of tissue samples from the upper
and lower intestine, and preparation of slides for
histological analysis has been previously described
(Brundige et al. 2008). Tissue samples to be used for
qRT-PCR analysis were snap frozen in liquid nitro-
gen before being stored at -70C until RNA
extraction.
Histology
Slides from pigs in the 2008 and 2009 feeding trials
were analyzed by photographing then measuring the
villi height, width, lamina propria thickness, and
crypt depth at 109 magnification, using Spot
Advanced Software (v3.4, Diagnostic Instruments).
In addition, the number of lymphocytes and goblet
cells per villus were counted at 409 magnification
and analyzed as cells per unit villous height. Four to
six villi were measured per slide. SAS statistical
software (SAS, Cary, NC, USA) was used to perform
statistical analysis. Tukey’s test was used determine
P-values and standard errors. A P value of B0.05 is
considered statistically significant.
RNA preparation and cDNA synthesis
Total RNA was isolated from the duodenum and
ileum samples from each animal from the 2004,
2006, 2008, and 2009 feeding trials using Trizol
Reagent (Invitrogen, Carlsbad, CA, USA) per man-
ufacturer’s instructions. RNA was quantified by
spectrophotometry and quality was determined by
running 1 lg of RNA on a 1% MOPS/formaldehyde
agarose gel.
For each sample used for cDNA synthesis, 1 lg of
RNA was combined with a master mix containing
OligoDT(18), 59 RT Buffer (Invitrogen), 0.1 M DTT,
RNasin, dNTPs, DNaseI, and DEPC dH20. Samples
were first DNase–treated to remove any residual
DNA by heating for 1 h at 37C, followed by heating
for 10 min at 70C to denature the DNase enzyme.
SuperScriptII reverse transcriptase (Invitrogen) was
then added for cDNA synthesis by heating at 40C for
Table 1 Pig ages and study durations for the 4 separate
feeding trials
Year Number of pigs
in each group
Age in days
at start of study
Days
fed
2004 4 14 15
2006 6 14 42
2008 3 14 25
2009 4 54 15
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1 h followed by heating to 70C for 10 min to destroy
any remaining enzyme. All resulting cDNA samples
were stored at -70C until used.
Genes and primers
Two genes, Ribosomal Protein L4 (RPL4) (Gen-
Bank# DQ845176) and TATA Box Binding Protein
(TBP) (GenBank# DQ845178), were chosen as
reference genes as both of these genes show stable
expression in the small intestine of pigs (Nygard et al.
2007). RPL4 was used as reference for high copy
number transcripts while TBP was used for low copy
number transcripts. Three target genes involved in the
inflammatory response were selected for evaluation:
pro-inflammatory cytokines TNF-a (GenBank#
X57321) and IL-8 (GenBank# NM_213867) and the
anti-inflammatory cytokine TGF-b1 (GenBank#
AF461808). TNF-a was selected because of the
demonstrated ability of lysozyme to interfere with its
activity. IL-8 was chosen because of its critical role
as a chemoattractant in inflammatory responses.
TGF-b1 was chosen because it is a major cytokine
in the GI tract.
Invitrogen LUX primers were designed using
GenBank porcine sequences and Invitrogen Lux
primer design software. Due to an incomplete Gen-
Bank sequence, additional sequence for use in design-
ing primers for TBP was obtained by using a Blast
search with the available GenBank sequence against
the DFCI Gene Index Project (http://compbio.dfci.
harvard.edu/tgi/) pig indices. All primers were
designed to span introns and yield products that were at
least 98 bp in length. Primer sets were labeled with
FAM dye (Table 2).
Real time qPCR conditions
All qPCR reactions were run in 96-well plates on an
ABI 7500 fast thermocycler. Each reaction contained
10 ll of 29 Fast SYBR Green (Applied Biosystems,
Foster City, CA, USA) probe master mix, 1 ll of
10 lM reverse primer, 1 ll of 10 lM forward primer,
cDNA and dH20 in a total sample volume of 20 ll.
Standard curves for each gene were constructed using
cDNA template consisting of pooled cDNA from
different pigs at concentrations of 300 ng/reaction
with 1:2 dilutions down to 4.68 ng/reaction. Three
standard curves were generated in three different
qPCR runs for each gene. To determine gene
expression in each experimental sample, a total of
50 ng cDNA was used with target genes being run on
the same plate as the reference genes.
Each 96-well plate was run using a 2-stage
thermocycling program. Amplification was carried
out in stage 1 and consisted of 3 steps: denaturation
for 15 s at 94C, annealing for 30 s at 60C, and
product extension for 30 s at 72C. Fluorescence data
was collected on the annealing step. Stage 1 was
repeated for a total of 40 cycles. In stage 2, disso-
ciation was measured in 3 steps: 95C for 15 s, 60C
for 1 min, and 95C for 15 s. For each plate,
threshold and baseline were individually set and CT
values determined using the 7500 Fast software.







RPL4 Ribosomal Protein L4 DQ845176 Fwd: CGATGCCACGCAAGAAGATTCAT[FC]G 99
Rev: GCATTGTCTTTGCATACGGGTTTA
TBP TATA Box Binding Protein DQ845178a Fwd: CGGGCATGAGAATAAGAGAACCC[FC]G 107
Rev: TCTTGCTGCTAGTCTGGACTGTTC
IL-8 Interlukin-8 NM_213867 Fwd: CGGGGAGACTAGAAAGAAAACAGCC[FC]G 152
Rev: GCGTATTTATGCACTGGCATCG
TGF-b1 Transforming Growth Factor b1 AF461808 Fwd: CGGACTACTACGCCAAGGAGGT 158
Rev: CGGAAGAGAGAGCAATACAGGTTC[FC]G
TNF-a Tumor Necrosis Factor X57321 Fwd: CCCTTGAGCATCAACCCTCTG 98
Rev: CGTTGTGCTTTGACATTGGCTACAA[FC]G
a With additional sequence from the DFCI Gene Index Project; [FC] = FAM-labeled cytosine
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Triplicate CT values were averaged for use in
calculations and statistics.
Quantitation analysis and statistics
Relative expression levels of each target gene and
fold differences in expression between the different
experimental groups for the duodenum and ileum
were calculated in a pair-wise fashion using the Pfaffl
method with REST-MCS software (Pfaffl et al.
2002). Briefly, the efficiency of each primer pair
was calculated from standard curve data. Each target
gene was normalized to TBP to determine pair-wise
fold differences in expression because TBP showed
the most consistent expression across studies.
P-values and standard errors for fold expression




There were no significant differences between dif-
ferent years within feeding groups for the histological
measurements; therefore data was pooled for analy-
sis. There were no significant differences between the
hLZ fed and control fed animals for the majority of
the histological parameters measured (Table 3). In
the duodenum, hLZ fed animals had significantly
thinner lamina propria (P = 0.0001) and tended to
have longer villi (P = 0.0923). Differences between
years were observed in the lymphocyte and goblet
cells, thus data was analyzed separately (Table 4). In
the duodenum lymphocytes were significantly
increased in hLZ fed animals in the 2008 study
(P = 0.009), while in the ileum, the 2008 hLZ fed
pigs had significantly decreased numbers of lympho-
cytes (P = 0.038). However in the 2009 study, the
hLZ fed pigs had significantly more lymphocytes
(P = 0.013) when compared to the controls. No
significant changes in goblet cells were observed,
however, in 2008 pigs fed hLZ milk tended to have
more goblet cells in the ileum (P = 0.055).
Quantitative real time PCR
There were no significant differences between dif-
ferent years within feeding groups for the cytokines
and data was pooled for analysis. Relative expression
rates of the three cytokines investigated are presented
in Table 5 with CT values that were adjusted using
TBP as a reference gene. Consumption of hLZ milk
resulted in a significant increase in expression of the
anti-inflammatory cytokine TGF-b1 in the ileum
(P = 0.047), but did not affect expression levels of
TNF-a or IL-8 in the duodenum or ileum.
Discussion
These experiments were done to expand and confirm
our previous results (Brundige et al. 2008) in order to
establish the general safety, and to quantify the
effects of feeding goat’s milk containing hLZ on key
Table 3 Histological measurements (lM) from the duodenum and ileum of pigs fed either pasteurized control milk or milk
containing hLZ
Number of villia Villus height Villus width Crypt depth Lamina Propria
Duodenum
Control (n = 7) 36 579.03 ± 26.09 171.78 ± 7.44 97.26 ± 9.78 237.37 ± 24.25
hLZ (n = 7) 32 631.29 ± 27.34 167.62 ± 6.86 105.27 ± 11.78 171.88 ± 10.99
P value 0.0923 0.6693 0.5474 0.0001*
Ileum
Control (n = 7) 52 440.14 ± 13.56 149.38 ± 4.83 71.68 ± 5.55 183.99 ± 11.51
hLZ (n = 7) 45 420.52 ± 13.56 146.14 ± 6.27 67.89 ± 6.17 163.63 ± 11.47
P value 0.1805 0.6601 0.6130 0.1830
* Denotes significance with a P value B0.05
a Number of villi counted for each group of animals
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markers of immune function in the small intestinal
epithelium of healthy pigs. We found through mea-
suring key cytokine levels and evaluating histology in
the pigs’ small intestine that the hLZ-containing milk
did not induce an inflammatory response in the gut
and improved some parameters associated with
gastrointestinal health. Specifically, we found higher
expression of TGF-b1, an anti-inflammatory cyto-
kine, and increased intestinal surface area in pigs fed
milk containing hLZ. Younger pigs from the 2008
study had an increased number of intraepithelial
lymphocytes (IEL’s) per lM villus height in the
duodenum, but a decreased number in the ileum as
opposed to older pigs from the 2009 study which had
increased lymphocytes in the ileum. Pigs fed hLZ in
2008 tended to have more goblet cells per unit villus
height in the ileum.
Finding significant increases in intraepithelial
lymphocytes (IEL) in the duodenum of older pigs
fed hLZ milk is consistent with other studies.
Pathogen free chickens given a mix of antimicrobial
peptides also had significantly more IEL’s in their
duodenum when compared to controls (Wang et al.
2009). This demonstrates that increases in IEL’s are
an indication of a well-primed and healthy gut and
IEL numbers can be raised with application of
antimicrobial peptides. Finding decreased lympho-
cytes in younger hLZ fed pigs also is consistent with
Table 4 Numbers of lymphocytes and goblet cells per unit of villous height in the duodenum and ileum of young pigs from the 2008
and 2009 feeding trials
Year Area of the gut Number of villia Lymphocytes/lM villi height P value Goblet cells/lM villi height P value
2008 Duodenum 18 Control (n = 3) 0.144 ± 0.008 0.009* Control (n = 3) 0.014 ± 0.001 0.207
16 hLZ (n = 3) 0.177 ± 0.009 hLZ (n = 3) 0.017 ± 0.002
Ileum 26 Control (n = 3) 0.168 ± 0.008 0.038* Control (n = 3) 0.035 ± 0.003 0.055
21 hLZ (n = 3) 0.146 ± 0.007 hLZ (n = 3) 0.042 ± 0.007
2009 Duodenum 18 Control (n = 4) 0.195 ± 0.011 0.446 Control (n = 4) 0.035 ± 0.003 0.891
16 hLZ (n = 4) 0.207 ± 0.013 hLZ (n = 4) 0.035 ± 0.004
Ileum 26 Control (n = 4) 0.163 ± 0.013 0.013* Control (n = 4) 0.036 ± 0.003 0.352
24 hLZ (n = 4) 0.202 ± 0.010 hLZ (n = 4) 0.041 ± 0.004
* Denotes significance with a P value B0.05
a Number of villi counted for each group of animals
Table 5 Levels of cytokines TNFa, IL-8, and TGF-b1 in the duodenum and ileum of pigs fed with hLZ-containing milk, or control
milk
Gene name Area of the gut Number of animals TBP adjusted CT value P value Fold change
in expression
TNFa Duodenum Control n = 17 31.582 ± 0.462 0.1876 NA
hLZ n = 17 32.394 ± 0.428
Ileum Control n = 17 32.662 ± 0.332 0.1177 NA
hlZ n = 17 31.951 ± 0.331
IL-8 Duodenum Control n = 17 28.381 ± 0.353 0.8427 NA
hLZ n = 17 28.473 ± 0.327
Ileum Control n = 17 28.156 ± 0.237 0.538 NA
hLZ n = 17 27.961 ± 0.236
TGF-b1 Duodenum Control n = 17 27.876 ± 0.603 0.6704 NA
hLZ n = 17 29.146 ± 0.559
Ileum Control n = 17 28.269 ± 0.179 0.0478* 0.492 :
hLZ n = 17 27.777 ± 0.178
* Denotes significance with a P value B 0.05
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previously reported results from feeding hLZ-con-
taining milk to young pigs (Brundige et al. 2008) and
hLZ-containing rice to chicks (Humphrey et al.
2002). In both of these studies, the decreases in
IEL’s were attributed to there being fewer microbial
challenges in the GI tract due to the antimicrobial
nature of hLZ. It has long been established that
animals fed antibiotics have thin intestinal walls with
few IEL’s, presumptively due to antibiotics reducing
microbiota populations and thus the stimulation of
the immune system (Berman and Weinstein, 1971).
We believe that differing results between the 2008
and 2009 cohorts are due to the different ages of
animals used in the two studies. As animals age, their
immune systems mature and increasing populations
of IEL’s are seen (Ishimoto et al. 2004). IEL numbers
in the intestine of pigs have been shown to increase
by a factor of 12 between day 1 and day 60 of life
(Pabst and Rothko¨tter, 1999). We hypothesize that
the lower IEL counts seen in the younger hLZ-fed
pigs are indicative of an advantageous decrease in
microbial challenges in the GI tract during early life,
when the neonate’s immune system has not yet fully
developed. However, as the pigs aged, we believe
that feeding hLZ milk caused IEL populations in the
gut to increase at a faster rate than in the controls,
producing a more mature immune system at an earlier
age. It is well known that breastfed infants experience
fewer gastrointestinal illnesses than bottle-fed infants
(Ip et al. 2007) and that breastfeeding aids in the
development of the intestinal mucosa and immune
system (Mountzouris et al. 2002; Newburg and
Walker 2007). The results of our current and previous
work (Brundige et al. 2008), taken together, support
hLZ-containing milk as lowering microbial chal-
lenges and enhancing the maturation of the immune
system in the gut. However, further work needs to be
completed in order to fully understand how hLZ-
containing milk affects the development of the IEL
population in the intestine as the animal ages.
Pigs fed hLZ in 2008 tended to have more goblet
cells per unit villus height in the ileum. Wang et al.
(2009) also found an increase in goblet cells in the
ileum. Goblet cells produce the protective mucus
layer that lines the intestine and is the first defense
against pathogenic bacteria (Duerkop et al. 2009). An
increase in goblet cells indicates an increased ability
to produce mucin, and thus protect the intestinal
epithelium. Histological data showed hLZ fed pigs
had significantly thinner lamina propria in the
duodenum and also tended to have taller villi in the
ileum. The thinning of the lamina propria is also
consistent with other studies done on the effects of
lysozyme on gut health. Chickens fed transgenic rice
containing lysozyme also had significantly thinner
lamina propria, as well as significantly higher feed
efficiency (Humphrey et al. 2002). A thinner lamina
propria is thought to be associated with increased
intestinal absorption and growth (Berman and Wein-
stein 1971).
The levels of three cytokines were investigated
and for both IL-8 and TNF-a there was no statisti-
cally significant difference between levels in hLZ and
control milk fed pigs. TNF-a is a strong pro-
inflammatory cytokine whose expression is greatly
increased during inflammation and infection. Ele-
vated levels of TNF-a can cause diarrhea, tissue
damage, and decreased digestive enzyme expression
(Turner 2009; Peuhkuri et al. 2010). Feeding hLZ-
containing milk to pigs did not increase the level of
TNF-a production, showing that consumption of the
milk did not induce an inflammatory response. The
pro-inflammatory cytokine IL-8 was also investigated
with the same finding. Pigs fed pasteurized hLZ milk
did not have elevated levels of TNF-a or IL-8,
supporting our conclusion that hLZ milk does not
cause inflammation.
We found that feeding hLZ milk significantly
increased levels of the anti-inflammatory cytokine
TGF-b1 in the ileum. This is consistent with the
findings of Lee et al. in 2009. They administered hen
egg derived lysozyme (HEL) to pigs with chemically
induced colitis, as well as healthy pigs. The healthy
pigs supplemented with HEL had significantly higher
levels of TGF-b1 than non-supplemented healthy
pigs. Although TGF-b1 is necessary for differentia-
tion of pathogenic Th17 cells, recent studies indicate
that heightened levels of TGF-b1 induces increased
levels of Foxp3, which reduces Th17 cell differen-
tiation (Zhou et al. 2008; Lee et al. 2009).
Elevated levels of TGF-b1 in the ileum may give
clues as to the mechanism by which lysozyme
modulated this cytokine. Consumption of hLZ milk
by pigs has been shown to significantly alter bacteria
populations in the small intestine (Maga et al. 2006c;
Brundige et al. 2008). There is a growing body of
evidence that commensal bacteria have an important
role in modulating cytokine levels and thus
Transgenic Res (2011) 20:1235–1243 1241
123
inflammatory response (Duerkop et al. 2009; Lalle`s
2010; Sharma and Tepas 2010; Shimizu 2010).
Changes in bacterial populations caused by hLZ
could cause an increase in TGF-b1 expression,
further protecting the gut from inflammation. Pre-
liminary data from the 2009 feeding trial suggests
pigs fed hLZ milk had increased numbers of
Lactobacillaceae and Bifidobacteriacea (unpublished
data), both of which are considered biomarkers of
increased gut health (Bourlioux et al. 2003). Admin-
istration of Lactobacillaceae has previously been
found to increase levels of TGF-b1 in the intestine
(Wallace et al. 2003; Torii et al. 2007). This
supports our hypothesis that lysozyme exerts a
protective effect on the gut by modulating the levels
of commensal bacteria, which in turn modulate
cytokine pathways, however further studies must be
done to confirm this.
The goal of this study was to investigate the
effects of hLZ milk on immune response in the
intestine and to confirm that the consumption of
pasteurized hLZ containing goats’ milk does not
cause an inflammatory response, using a porcine
model. The hLZ milk did not cause increased
expression of pro-inflammatory cytokines TNF-a or
IL-8, which supports our hypothesis. It also
increased IEL’s and goblet cells, two cell types
that are part of the first line of defense in the gut,
creating an intestinal epithelial layer that is better
prepared to protect against pathogenic bacteria.
Finally, hLZ significantly increased production of
anti-inflammatory cytokine TGF-b1 in the ileum.
All of these changes suggest that the consumption
of pasteurized hLZ improves the overall gastroin-
testinal health of the growing pig.
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